🔎 Trials Near Me

Beranda › Kanker Paru Non-Sel Kecil › California › San Bernardino

Uji klinis Kanker Paru Non-Sel Kecil di San Bernardino, CA

9 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar San Bernardino (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Menerima pesertaFase 3
  • Loma Linda University Medical Center, Loma Linda · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT04267848

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Menerima pesertaFase 3
  • Veterans Affairs Loma Linda Healthcare System, Loma Linda · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06498635

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

Menerima pesertaFase 3
  • Local Institution - 0682, Loma Linda · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06875310

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Menerima pesertaFase 3
  • Research Site, Loma Linda · 4 mi jauhnya
  • Research Site, Redlands · 7 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06692738

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

Menerima pesertaFase 3
  • Research Site, Loma Linda · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07291037

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Menerima pesertaFase 2
  • Loma Linda University Medical Center, Loma Linda · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Jun 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Menerima pesertaFase 2
  • Loma Linda University Medical Center, Loma Linda · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Menerima pesertaFase 2/3
  • Loma Linda University Medical Center, Loma Linda · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Mei 2026 · NCT06616584

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

Menerima pesertaFase 1/2
  • Emad Ibrahim MD Inc, Redlands · 7 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Okt 2025 · NCT06228326

Uji klinis Kanker Paru Non-Sel Kecil di kota lain

Studi lain di San Bernardino

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.